Invivyd, Inc., a biotechnology company, has scheduled its 2024 Annual Meeting of Stockholders to be held virtually on May 21, 2024. The meeting will address the election of seven director nominees, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and other business matters. The Board recommends voting FOR ALL director nominees and FOR the ratification of PricewaterhouseCoopers LLP. Proxy materials will be mailed to stockholders around April 18, 2024, and will include instructions on how to vote and access the Proxy Statement and the 2023 Annual Report on Form 10-K. The record date for determining stockholders eligible to vote at the meeting is March 22, 2024. The meeting will be accessible online, with no in-person attendance option, and stockholders will be able to submit questions and vote during the live webcast.

Invivyd, Inc., a biotechnology company, has scheduled its 2024 Annual Meeting of Stockholders to be held virtually on May 21, 2024. The meeting will address the election of seven director nominees, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and other business matters. The Board recommends voting FOR ALL director nominees and FOR the ratification of PricewaterhouseCoopers LLP. Proxy materials will be mailed to stockholders around April 18, 2024, and will include instructions on how to vote and access the Proxy Statement and the 2023 Annual Report on Form 10-K. The record date for determining stockholders eligible to vote at the meeting is March 22, 2024. The meeting will be accessible online, with no in-person attendance option, and stockholders will be able to submit questions and vote during the live webcast.